Empagliflozin impact on experimentally induced acetaminophen toxicity: Imprint of mitochondrial dynamics, biogenesis, and cGAS/STING signal in amending liver insult

Abstract

AbstractAcetaminophen (APAP) is one of the most clinically relevant medications associated with acute liver damage. A prolific deal of research validated the hepatoprotective effect of empagliflozin (EMPA); however, its effect on APAP‐induced hepatotoxicity has still not been investigated. In this study, the prospective hepatoprotective impact of EMPA against APAP‐induced hepatotoxicity was investigated. Twenty‐eight Balb‐C mice were assigned to four groups: control, APAP, EMPA10/APAP, and EMPA25/APAP. At the end of the experiment, serum hepatotoxicity biomarkers, MDA level, and GSH content were estimated. Hepatic mitofusin‐2 (MFN2), optic atrophy 1 (OPA1), dynamin‐related protein 1 (Drp1), and mitochondrial fission 1 protein (FIS1) were immunoassayed. PGC‐1α, cGAS, and STING mRNA expression were assessed by real‐time PCR. Histopathological changes and immunohistochemistry of INF‐β, p‐NF‐κB, and iNOS were evaluated. APAP treatment caused significant hepatic functional impairment and increased hepatic MDA levels, as well as a concomitant decrease in GSH content. Marked elevation in Drp1 and FIS1 levels, INF‐ß, p‐NF‐κB, and iNOS immunoreactivity, and reduction in MFN2 and OPA1 levels in the APAP‐injected group, PGC‐1α downregulation, and high expression of cGAS and STING were also documented. EMPA effectively ameliorated APAP‐generated structural and functional changes in the liver, restored redox homeostasis and mitochondrial dynamics balance, and enhanced mitochondrial biogenesis, remarkably diminished hepatic expression of cGAS and STING, and elicited a reduction in hepatic inflammation. Moreover, the computational modeling data support the interaction of APAP with antioxidant system‐related proteins as well as the interactions of EMPA against Drp1, cGAS, IKKA, and iNOS proteins. Our findings demonstrated for the first time that EMPA has an ameliorative impact against APAP‐induced hepatotoxicity in mice via modulation of mitochondrial dynamics, biogenesis, and cGAS/STING‐dependent inflammation. Thus, this study concluded that EMPA could be a promising therapeutic modality for acute liver toxicity.